Osteopontin modulates angiotensin II–induced inflammation, oxidative stress, and fibrosis of the kidney
- 1 July 2009
- journal article
- Published by Elsevier in Kidney International
- Vol. 76 (1) , 32-43
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial originAmerican Journal of Physiology-Renal Physiology, 2007
- Epithelial to Mesenchymal Transition and Peritoneal Membrane Failure in Peritoneal Dialysis PatientsJournal of the American Society of Nephrology, 2007
- MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesityJournal of Clinical Investigation, 2006
- Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injuryKidney International, 2006
- Angiotensin II stimulates α3(IV) collagen production in mouse podocytes via TGF-β and VEGF signalling: implications for diabetic glomerulopathyNephrology Dialysis Transplantation, 2005
- Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathyKidney International, 2005
- Human Urotensin II Is a Novel Activator of NADPH Oxidase in Human Pulmonary Artery Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Role of Osteopontin in Cardiac Fibrosis and Remodeling in Angiotensin II-Induced Cardiac HypertrophyHypertension, 2004
- Phagocytosis induces superoxide formation and apoptosis in macrophagesExperimental & Molecular Medicine, 2003
- Prevalence and characteristics of individuals with chronic kidney disease in a large health maintenance organizationAmerican Journal of Kidney Diseases, 2001